Inventor · disambiguated record
Alexis Kalergis
Also filed as: KALERGIS ALEXIS · KALERGIS ALEXIS M
1 granted patent·3 pending applications·0 citations·filing 2011–2021
14Inventor score
Top patents by PatentIndex Score
4 records- 0143US2023210977A1NOVEL USE OF BCG IMMUNOGENIC FORMULATION EXPRESSING A HUMAN RESPIRATORY SYNCYTIAL VIRUS PROTEIN AGAINST bRSV IN CATTLEUNIV PONTIFICIA CATOLICA CHILE·Filed 2021·Application pending·0 cites
- 0242US2023055706A1NEW USE OF BCG IMMUNOGENIC FORMULATION EXPRESSING A RESPIRATORY SYNCITIAL VIRUS PROTEIN AGAINST hMPVUNIV PONTIFICIA CATOLICA CHILE·Filed 2020·Application pending·0 cites
- 0340US9849141B2Use of spironolactone-based composition that exhibits an inhibitory action on T-lymphocyte activation which is useful for preventing and/or treating multiple sclerosisUNIV PONTIFICIA CATOLICA CHILE·Filed 2013·Granted Dec 26, 2017·0 cites·7 claims
- 0422US2013203719A1Use of spironolactone-based composition that exhibits an inhibitory action on t-lymphocyte activation which is usefule for preventing and/or treating multiple sclerosisKALERGIS ALEXIS M·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alexis Kalergis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →